Congenital platelet disorders and understanding of platelet function

British Journal of Haematology

Volumn 165, Issue 2, 2014, Pages 165-178

  Nurden, Alan T ^a   Nurden, Paquita ^a  

^a Ctr Geriatrie Ctr Hosp Univ B   (France)

Author keywords

Bleeding disorders; Haemostasis; Mutations; Platelets

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN RECEPTOR; THROMBIN RECEPTOR; THROMBOXANE A2 RECEPTOR;

BERNARD SOULIER DISEASE; BINDING SITE; CELL DENSITY; CHROMOSOMAL LOCALIZATION; DOWN REGULATION; GAIN OF FUNCTION MUTATION; GENETIC ASSOCIATION; GLANZMANN DISEASE; GRAY PLATELET SYNDROME; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCOTT SYNDROME; SECRETORY GRANULE; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE ANOMALY; THROMBOCYTE DISORDER; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA;

BLEEDING DISORDERS; HAEMOSTASIS; MUTATIONS; PLATELETS;

BLOOD COAGULATION DISORDERS, INHERITED; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; HUMANS; PLATELET ADHESIVENESS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; THROMBASTHENIA;

EID: 84898058464     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12662     Document Type: Review

References (103)

1. 2α deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. The Journal of Clinical Investigation, 118, 2121-2131.
2. Al Hawas, R., Ren, Q., Ye, S., Karim, Z.A., Filipovich, A.H. & Whiteheart, S.W. (2012) Munc 18b/STXB2 is required for platelet secretion. Blood, 120, 2493-2500.
3. Albers, C.A., Cvejic, A., Favier, R., Bouwmans, E.E., Alessi, M.C., Bertone, P., Jordan, G., Kettleborough, R.N., Kiddle, G., Kostadima, M., Read, R.J., Sipos, B., Sivapalaratnam, S., Smethurst, P.A., Stephens, J., Voss, K., Nurden, A., Rendon, A., Nurden, P. & Ouwehand, W.H. (2011) Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nature Genetics, 43, 735-737.
4. Albers, C.A., Paul, D.S., Schulze, H., Freson, K., Stephens, J.C., Smethurst, P.A., Jolley, J.D., Cvejic, A., Kostadima, M., Bertone, P., Breuning, M.H., Debili, N., Deloukas, P., Favier, R., Fiedler, J., Hobbs, C.M., Huang, N., Hurles, M.E., Kiddle, G., Krapels, I., Nurden, P., Ruivenkamp, C.A., Sambrook, J.G., Smith, K., Stemple, D.L., Strauss, G., Thys, C., Van Geet, C., Newbury-Ecob, R., Ouwehand, W.H. & Ghevaert, C. (2012) Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nature Genetics, 44, 435-439.
5. Aluti, A., Blasco, L., Scaramuzza, S., Ferrua, F., Cicalese, M.P., Baricordi, C., Dionisio, F., Calabria, A., Gianelli, S., Castiello, M.C., Bosticardo, M., Evangelio, C., Assanelli, A., Casiraghi, M., Di Nunzio, S., Callegaro, L., Benati, C., Rizzardi, P., Pellin, D., Di Serio, C., Schmidt, M., Von Kalle, K., Gardner, J., Mehta, N., Neduva, V., Dow, D.J., Galy, A., Miniero, R., Finocchi, A., Metin, A., Banerjee, P.P., Orange, J.S., Galimberti, S., Valsecchi, M.G., Biffi, A., Montini, E., Villa, A., Ciceri, F., Roncarolo, M.G. & Naldini, L. (2013) Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science, 341, 6148.
6. Balduini, A., Malara, A., Pecci, A., Badalucco, S., Bozzi, V., Pallotta, I., Noris, P., Torti, M. & Balduini, C.L. (2009) Proplatelet formation in heterozygous Bernard-Soulier syndrome type Bolzano. Journal of Thrombosis and Haemostasis, 7, 478-484.
7. Balduini, C.L., Pecci, A. & Savoia, A. (2011) Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. British Journal of Haematology, 154, 161-174.
8. Balduini, C.L., Savoia, A. & Seri, M. (2013) Inherited thrombocytopenias frequently diagnosed in adults. Journal of Thrombosis and Haemostasis, 11, 1006-1019.
9. Bender, M., Hoffmann, S., Stegner, D., Chalaris, A., Bosi, M., Braun, A., Scheller, J., Rose-John, S. & Nieswandt, B. (2010) Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood, 116, 3347-3355.
10. Bennett, J.S. & Rao, A.K. (2012) Inherited disorders of platelet function. In: Hemostasis and Thrombosis, Basic Principles and Clinical Practice, VI edn (ed. by V.J. Marder, W.C. Aird, J.S. Bennett, S. Schulman & G.C. White II), pp. 805-820. Wolters Kluwer/Lippincott, Williams & Wilkins, Philadelphia.
11. Berndt, M.C. & Andrews, R.K. (2011) Bernard-Soulier syndrome. Haematologica, 96, 355-359.
12. Berrou, E., Adam, F., Lebret, M., Fergelot, P., Kauskot, A., Coupry, I., Jandrot-Përrus, M., Nurden, A., Favier, R., Rosa, J.-P., Goizet, C., Nurden, P. & Bryckaert, M. (2013) Heterogeneity of platelet functional alterations in patients with filamin A mutations. Arteriosclerosis, Thrombosis and Vascular Biology, 33, e11-e18.
13. Blavignac, J., Bunimov, N., Rivard, G.E. & Hayward, C.P. (2011) Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment. Seminars in Thrombosis and Haemostasis, 37, 713-720.
14. Bluteau, D., Glembotsky, A.C., Raimbault, A., Balayn, N., Gilles, L., Rameau, P., Nurden, P., Alessi, M.C., Debili, N., Vainchenker, W., Heller, P.G., Favier, R. & Raslova, H. (2012) Dysmegakaryopoiesis of FDP/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression. Blood, 120, 2708-2718.
15. Bottega, R., Pecci, A., De Candia, E., Pujol-Moix, N., Heller, P.G., Noris, P., De Rocco, D., Podda, G.N., Glembotsky, A.C., Cattaneo, M., Balduini, C.L. & Savoia, A. (2013) Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency. Haematologica, 98, 868-874.
16. Bunimov, N., Fuller, N. & Hayward, C.P.M. (2013) Genetic loci associated with platelet traits and platelet disorders. Seminars in Thrombosis and Hemostasis, 39, 291-305.
17. Bury, L., Malara, A., Gresele, P. & Balduini, A. (2012) Outside-in signaling generated by a constitutively activated integrin αIIbβ3 impairs proplatelet formation in human megakaryocytes. PLoS ONE, 7, e3449.
18. Cattaneo, M. (2011) Molecular defects of the platelet P2 receptors. Purinergic Signalling, 7, 333-339.
19. Cattaneo, M. & Gachet, C. (1998) ADP receptors and clinical bleeding disorders. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 2281-2285.
20. Coller, B.S. & Shattil, S.J. (2008) The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns and even a bend. Blood, 112, 3011-3025.
21. Cosemans, J.M.E.M., Angelillo-Scherer, A., Mattheij, N.J.A. & Heemskerk, J.W.M. (2013) The effects of arterial flow on platelet activation, thrombus growth, and stabilization. Cardiovascular Research, 99, 342-352.
22. Cullinane, A.R., Curry, J.A., Carmona-Rivera, C., Summers, C.G., Ciccone, C., Cardillo, N.D., Dorwood, H., Hess, R.A., White, J.G., Adams, D., Huizing, M. & Gahl, W.A. (2011) A BLOC-1 mutation screen reveals that PLDN is mutated in Hermansky-Pudlak syndrome type 9. American Journal of Human Genetics, 88, 778-787.
23. Cunningham, M.R., Nisar, S.P., Cooke, A.E., Emery, E.D. & Mundell, S.J. (2013) Differential endosomal sorting of a novel P2Y12 purinoreceptor mutant. Traffic, 14, 585-598.
24. Dawood, B., Lowe, G.C., Lordkipanidzé, M., Bern, D., Daly, M.E., Makris, M., Mumford, A., Wilde, J.T. & Watson, S.P. (2012) Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood, 120, 5041-5049.
25. Deppermann, C., Cherpokova, D., Nurden, P., Schulz, J.N., Thielmann, I., Kraft, P., Vögtle, T., Kleinschnitz, C., Dütting, S., Krohne, G., Eming, S.A., Eckes, B., Stoll, G., Stegner, D. & Niesswandt, B. (2013) Gray platelet syndrome and defective thrombo-inflammation in NBEAL2-deficient mice. The Journal of Clinical Investigation, 123, 3331-3342.
26. Dumont, B., Lasne, D., Rothschild, C., Bouabdelli, M., Olivier, V., Oudin, C., Ajzenberg, N., Grandchamp, B. & Jandrot-Perrus, M. (2009) Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood, 114, 1900-1903.
27. Enayat, S., Ravanbod, S., Rassoulzadegan, M., Jazebi, M., Tarighat, S., Ala, F., Emsley, J. & Othman, M. (2012) A novel D235Y mutation in the GP1BA gene enhances platelet interaction with von Willebrand factor in an Iranian family with platelet-type von Willebrand disease. Thrombosis and Haemostasis, 108, 946-954.
28. Fang, J., Jensen, E.S., Boudreaux, M.K., Du, L.M., Hawkins, T.B., Koukouritaki, S.B., Cornetta, K. & Wilcox, D.A. (2011) Platelet gene therapy improves hemostatic function for integrin αlphaIIbbeta3-deficient dogs. Proceedings of the National Academy of Sciences USA, 108, 9583-9588.
29. Fang, J., Nurden, P., North, P., Nurden, A.T., Du, L.M., Valentin, N. & Wilcox, D.A. (2013) C560Rβ3 caused platelet integrin αIIbβ3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality. Journal of Thrombosis and Haemostasis, 11, 1163-1171.
30. Faraday, N., Yanek, L.R., Yang, X.P., Mathias, R., Herrera-Galeano, J.E., Suktitipat, B., Qayyum, R., Johnson, A.D., Chen, M.H., Tofier, G.H., Ruczinski, I., Friedman, A.D., Gylfason, A., Thorsteinsdottir, U., Bray, P.F., O'Donnell, C.J., Becker, D.M. & Becker, L.C. (2011) Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression. Blood, 118, 3367-3375.
31. Geneviève, D., Proulle, V., Isidor, B., Bellais, S., Serre, V., Djouadi, F., Picard, C., Vignon-Savoye, C., Bader-Meunier, B., Blanche, S., de Vernejoul, M.-C., Legeai-Mallet, L., Fischer, A.-M., Le Merrer, M., Dreyfus, M., Gaussem, P., Munnich, A. & Cormier-Daire, V. (2008) Thromboxane synthase mutations in an inherited bone density disorder (Ghosal syndrome). Nature Genetics, 40, 284-286.
32. Gochuico, B.R., Huizing, M., Golas, G.A., Scher, C.D., Tsokos, M., Denver, S.D., Frei-Jones, M.J. & Gahl, W.A. (2012) Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome Type 2, an adaptor protein-3 complex disease. Molecular Medicine, 18, 56-64.
33. Golder, M., Pruss, C.M., Hegadorm, C., Mewburn, J., Laverty, K., Sponagle, K. & Lillicrap, D. (2010) Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions. Blood, 115, 4862-4869.
34. Gunay-Aygun, M., Zivony-Elboum, Y., Gumruk, F., Geiger, D., Cetin, D., Khayat, M., Khieta, R., Kfir, N., Anikster, Y., Chezar, J., Arcos-Burgos, M., Shalata, A., Stanescu, H., Manaster, J., Arat, M., Edwards, H., Freiberg, A.S., Hart, P.S., Riney, L.C., Patzel, K., Tanpaiboon, P., Markello, T., Huizing, M., Marisc, I., Horne, M., Kehrel, B.E., Jurk, K., Hansen, N.F., Cherkuri, P.F., Jones, M., Cruz, P., Mulikin, J.C., Nurden, A., White, J.G., Gahl, W.A. & Falik-Zaccai, T. (2010) Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood, 116, 4990-5001.
35. Gunay-Aygun, M., Falik-Zaccai, T.C., Vilboux, T., Zivony-Elboum, Y., Gumruk, F., Cetin, M., Khayat, M., Boerkoel, C.F., Kfir, N., Huang, Y., Maynard, D., Dorward, H., Berger, K., Kieta, R., Anikster, Y., Arat, M., Freiberg, A.S., Kehrel, B.E., Jurk, K., Cruz, P., Mulikin, J.C., White, J.G., Huizing, M. & Gahl, W.A. (2011) NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Nature Genetics, 43, 732-734.
36. Habert, D., Cheli, Y., Nugent, D.J., Ruggeri, Z.M. & Kunicki, T.J. (2013) Conditional knockout of integrin α2β1 in murine megakaryocytes leads to reduced mean platelet volume. PLoS ONE, 8, e55094.
37. Harris, E.S., Weyrich, A.S. & Zimmerman, G.A. (2013) Lessons from rare maladies: leukocyte adhesion deficiency syndromes. Current Opinion in Hematology, 20, 16-25.
38. Hermans, C., Wittevrongel, C., Thys, C., Smethurst, P.A., Van Geet, C. & Freson, K. (2009) A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder. Journal of Thrombosis and Haemostasis, 7, 1356-1363.
39. 60 to Leu mutation. Journal of Clinical Investigation, 97, 949-956.
40. Hollopeter, G., Jantzen, H.-M., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R.B., Nurden, P., Nurden, A., Julius, D. & Conley, P.B. (2001) Molecular identification of the platelet receptor targeted by antithrombotic drugs. Nature, 409, 202-207.
41. Hughan, S.C., Senis, Y., Best, D., Thomas, A., Frampton, J., Vyas, P. & Watson, S.P. (2005) Selective impairment of platelet activation to collagen in the absence of GATA1. Blood, 105, 4369-4376.
42. Huizing, M., Helip-Wooley, A., Westbroek, W., Gunay-Aygun, M. & Gahl, W.A. (2008) Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics. Annual Reviews of Genomics and Human Genetics, 9, 359-386.
43. Jalagadugula, G., Mao, G., Kaur, G., Dhanasekaran, D.N. & Rao, A.K. (2011) Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1. Arteriosclerosis Thrombosis and Vascular Biology, 31, 921-927.
44. Kahr, W.H.A., Hinckley, J., Li, L., Schwertz, H., Christensen, H., Rowley, J.W., Pluthero, F.G., Urban, D., Fabbro, S., Nixon, B., Gadzinski, R., Storck, M., Wang, K., Ryu, G.Y., Jobe, S.M., Schutte, B.C., Moseley, J., Loughran, N.B., Parkinson, J., Weyrich, A.S. & Paola, J. (2011) Mutations in NBEAL2 encoding a beach protein, cause gray platelet syndrome. Nature Genetics, 43, 738-740.
45. -/- mice. Blood, 122, 3349-3358.
46. Kannan, M., Ahmad, F., Yadav, B.K., Kumar, R., Choudhry, V.P. & Saxena, R. (2009) Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann thrombasthenia. Journal of Thrombosis and Haemostasis, 7, 1878-1885.
47. Kashiwagi, H., Kunishima, S., Kiyomizu, K., Amano, Y., Shimado, H., Morishita, M., Kanarkura, Y. & Tomiyama, Y. (2013) Demonstration of novel gain-of-function mutations of αIIbβ3: association with macrothrombocytopenia and glanzmann-thrombasthenia-like phenotype. Molecular Genetics & Genomic Medicine, 1, 77-86.
48. Kunicki, T.J., Williams, S.A. & Nugent, D.J. (2012) Genetic variants that affect platelet function. Current Opinion in Hematology, 9, 371-379.
49. Kunishima, S., Okuno, Y., Yoshida, K., Shiraishi, Y., Sanada, M., Murammatsu, H., Chiba, K., Tanaka, H., Miyazaki, K., Sakai, M., Ohtake, M., Kobayashi, R., Iguchi, A., Nimi, G., Otsu, M., Takahashi, Y., Miyano, S., Saito, H., Kojima, S. & Ogawa, S. (2013) ACTN1 mutations cause congenital macrothrombocytopenia. American Journal of Human Genetics, 92, 431-438.
50. Lanza, F. (2006) Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy). Orphanet Journal of Rare Diseases, 1, 46.
51. Lhermusier, T., Chap, H. & Payrastre, B. (2011) Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome. Journal of Thrombosis and Haemostasis, 9, 1883-1891.
52. Li, R. & Emsley, J. (2013) The organizing principle of the platelet glycoprotein Ib-IX-V complex. Journal of Thrombosis and Haemostasis, 11, 605-614.
53. Louwette, S., Van Geet, C. & Freson, K. (2012) Regulators of G protein signaling (RGS): role in hematopoiesis, megakaryopoiesis and platelet function. Journal of Thrombosis and Haemostasis, 10, 2215-2222.
54. Mahlaoui, N., Pellier, I., Mignot, C., Jais, J.P., Bilhou-Nabéra, C., Moshous, D., Neven, B., Picard, C., de Saint-Basile, G., Cavazzana-Calvo, M., Blanche, S. & Fischer, A. (2013) Characteristics and outcome of early onset, severe forms of Wiskott-Aldrich syndrome. Blood, 121, 1510-1516.
55. Mansour, W., Einay, Y., Hauschner, H., Koren, A., Seligsohn, U. & Rosenberg, N. (2011) An αIIb mutation in patients with Glanzmann thrombasthenia located in the N-terminus of blade 1 of the β-propeller (Asn2Asp) disrupts a calcium binding site in blade 6. Journal of Thrombosis and Haemostasis, 9, 192-200.
56. Masliah-Planchon, J., Darnige, L. & Bellucci, S. (2012) Molecular determinants of platelet delta storage pool deficiencies: an update. British Journal of Haematology, 160, 5-11.
57. Matus, V., Valenzuela, G., Saez, C.G., Hidalgo, P., Lagos, M., Aranda, E., Panes, O., Pereira, J., Pillois, X., Nurden, A.T. & Mezzano, D. (2013) An adenine insertion in exon 6 of human GP6 generates a truncated protein associated with a bleeding disorder in 4 Chilean families. Journal of Thrombosis and Haemostasis, 11, 1751-1759.
58. McEwan, P.A., Yang, W., Carr, K.H., Mo, X., Zheng, X., Li, R. & Emsley, J. (2011) Quaternary organization of GPIb-IX complex and insights into Bernard-Soulier syndrome revealed by the structures of GPIbβ and a GPIbβ/GPIX chimera. Blood, 118, 5292-5301.
59. Meng, R., Wang, Y., Yao, Y., Zhang, Z., Harper, D.C., Heijnen, H.F., Sitaram, A., Li, W., Raposo, G., Weiss, M.J., Poncz, M. & Marks, M.S. (2012) SLC35D3 delivery from megakaryocyte early endosomes is required for platelet dense granule biogenesis and is differentially defective in Hermansky-Pudlak syndrome models. Blood, 120, 404-414.
60. Mor-Cohen, R., Rosenberg, N., Einav, Y., Zelzion, E., Landau, M., Mansour, W., Averbukh, Y. & Seligsohn, U. (2012) Unique disulfides in epidermal growth factor (EGF) domains of β3 affect structure and function of αIIbβ3 and αIIbβ3 integrins in different manner. Journal of Biological Chemistry, 287, 8879-8891.
61. Muller, F., Mutch, N.J., Schenk, W.A., Smith, S.A., Esteri, L., Spronk, H.M., Schmidbauer, S., Gahl, W.A., Morrissey, J.H. & Renné, T. (2009) Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell, 139, 1143-1156.
62. Mumford, A.D., Nisar, S., Darnige, L., Jones, M.L., Bachelot-Loza, C., Gandrille, S., Zinzindohoue, F., Fischer, A.M., Mundell, S.J., Gaussem, P. & UK GAPP Study Group (2013) Platelet dysfunction associated with the novel Trp29Cys thromboxane A2 receptor variant. Journal of Thrombosis and Haemostasis, 11, 547-554.
63. Nash, C.A., Séverin, S., Dawood, B.B., Makris, M., Mumford, A., Wilde, J., Senis, Y.A. & Watson, S.P. (2010) Src family kinases are essential for primary aggregation by G(i)-coupled receptors. Journal of Thrombosis and Haemostasis, 8, 2273-2282.
64. Noris, P., Perrotta, S., Seri, M., Pecci, A., Gnan, C., Loffredo, G., Pujol-Moix, N., Zecca, M., Scognamiglio, F., De Rocco, D., Punzo, F., Melazzini, F., Scianguetta, S., Casale, M., Marconi, C., Pippucci, T., Amendola, G., Notarangelo, L.D., Kiersy, C., Civaschi, E., Balduini, C.L. & Savoia, A. (2011) Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood, 117, 6673-6680.
65. Noris, P., Perrotta, S., Bottega, R., Pecci, A., Melazzini, F., Civaschi, E., Russo, S., Magrin, S., Loffredo, G., Di Salvo, V., Russo, G., Casale, M., De Rocco, D., Grignani, C., Cattaneo, M., Baronci, C., Dragani, A., Albano, V., Jankovic, M., Scianguetta, S., Savoia, A. & Balduini, C.L. (2012) Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation). Haematologica, 97, 82-88.
66. Nurden, A.T. & Caen, J.P. (1974) An abnormal platelet glycoprotein in three cases of Glanzmann thrombasthenia. British Journal of Haematology, 28, 253-260.
67. Nurden, A.T. & Nurden, P. (2011) Advances in our understanding of the molecular basis of disorders of platelet function. Journal of Thrombosis and Haemostasis, 9, 76-91.
68. Nurden, P. & Nurden, A.T. (2012) Inherited thrombocytopenias. In: Hemostasis and Thrombosis, Basic Principles and Clinical Practice, VI edn (ed. by V.J. Marder, W.C. Aird, J.S. Bennett, S. Schulman & G.C. White II), pp. 785-795. Wolters Kluwer/Lippincott, Williams & Wilkins, Philadelphia.
69. Nurden, P., Savi, P., Heilmann, E., Bihour, C., Herbert, J.M., Maffrand, J.P. & Nurden, A. (1995) An inherited bleeding disorder linked to a defective interaction between ADP and its receptor in platelets. Its influence on glycoprotein IIb-IIIa complex function. Journal of Clinical Investigation, 95, 1612-1622.
70. Nurden, P., Gobbi, G., Nurden, A., Enouf, J., Youlyouz-Marfak, I., Carubbi, C., La Marca, S., Punzo, M., Baronciani, L., De Marco, L., Vitale, M. & Federici, A. (2010) Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B. Blood, 115, 2649-2656.
71. Nurden, A.T., Fiore, M., Nurden, P. & Pillois, X. (2011a) Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on phenotypic variability and mouse models. Blood, 118, 5996-6005.
72. Nurden, P., Debili, N., Coupry, I., Bryckaert, M., Youlyouz-Marfak, I., Solé, G., Pons, A.C., Berrou, E., Adam, F., Kauskot, A., Lamazière, J.M., Rameau, P., Fergelot, P., Rooryck, C., Cailley, D., Arveiler, B., Lacombe, D., Vainchenker, W., Nurden, A. & Goizet, C. (2011b) Thrombocytopenia resulting from mutations in filamin A can be expressed as an isolated syndrome. Blood, 118, 5928-5937.
73. Nurden, A.T., Pillois, X. & Nurden, P. (2012) Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment. Expert Review of Hematology, 5, 487-503.
74. Nurden, A.T., Pillois, X. & Wilcox, D.A. (2013) Glanzmann thrombasthenia: state of the art and future directions. Seminars in Thrombosis and Hemostasis, 39, 642-655.
75. Nürnberg, S.T., Rendon, A., Smethurst, P.A., Paul, D.S., Voss, K., Thon, J.N., Lloyd-Jones, H., Sambrook, J.G., Tijssen, M.R.; HaemGen Consortium, Italiano, J.E. Jr, Deloukas, P., Gottgens, B., Soranzo, N. & Ouwehand, W.H. (2012) A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site. Blood, 120, 4859-4468.
76. Othman, M. (2011) Platelet-type von Willebrand disease: a rare, often misdiagnosed and underdiagnosed bleeding disorder. Seminars in Thrombosis and Hemostasis, 37, 464-469.
77. Patterson, A.D., Rommens, J.M., Bharaj, B., Blavignac, J., Wong, I., Diamondis, M., Waye, J.S., Rivard, G.E. & Hayward, C.P.M. (2010) Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene. Blood, 115, 1264-1266.
78. Pecci, A., Bozzi, V., Panza, E., Barozzi, S., Gruppi, C., Seri, M. & Balduini, C.L. (2011) Mutations responsible for MYH9-related thrombocytopenia impair SDF-1 driven migration of megakaryoblastic cells. Thrombosis and Haemostasis, 106, 693-704.
79. Peitsidis, P., Datta, T., Pafilis, I., Otomewo, O., Tuddenham, E.G.D. & Kadir, R.A. (2010) Bernard-Soulier syndrome in pregnancy: a systematic review. Haemophilia, 16, 584-591.
80. Peters, C.G., Michelson, A.D. & Flaumenhaft, R. (2012) Granule exocytosis is required for platelet spreading: differential sorting of α-granules expressing VAMP-7. Blood, 120, 199-206.
81. Pignatelli, P., Carnevale, R., Di Santo, S., Bartimoccia, S., Sanguigni, V., Lenti, L., Finocchi, A., Mendolicchio, L., Soresina, A.R., Plebani, A. & Violi, F. (2011) Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction. Arteriosclerosis, Thrombosis and Vascular Biology, 31, 423-434.
82. Rand, M.L., Wang, H., Bang, K.W.A., Teitel, J.M., Blanchette, V.S., Freedman, J. & Nurden, A.T. (2010) Phosphatidylserine exposure and other apoptotic-like events in Bernard-Soulier syndrome platelets. American Journal of Hematology, 85, 584-592.
83. Rayes, J., Hollestelle, M.J., Legendre, P., Marx, I., de Groot, P., Christophe, O.D., Lenting, P.J. & Denis, C.V. (2010) Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B. Blood, 115, 4870-4877.
84. Roca-Cusachs, P., del Rio, A., Puklin-Faucher, E., Gauthier, N.C., Biais, N. & Sheetz, M.P. (2013) Integrin-dependent force transmission to the extracellular matrix by α-actinin triggers adhesion maturation. Proceedings of the National Academy of Sciences USA, 110, E1361-E1370.
85. Sandrock, K., Nakamura, L., Vraetz, T., Beuthel, K., Ehl, S. & Zieger, B. (2010) Platelet secretion defect in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5). Blood, 116, 6148-6149.
86. Savoia, A., Pastore, A., De Rocco, D., Civaschi, E., Di Stazio, M., Bottega, R., Melazzini, F., Bozzi, V., Pecci, A., Magrin, S., Balduini, C.L. & Boris, P. (2011) Clinical and genetic aspects of Bernard-Soulier syndrome: searching for genotype/phenotype correlations. Haematologica, 96, 417-423.
87. Schachtner, H., Calaminus, S.D.J., Sinclair, A., Monypenny, J., Blundell, M.P., Leon, C., Holyoake, T.L., Thrasher, A.J., Michie, A.M., Vukovic, M., Gachet, C., Jones, G.E., Thomas, S.G., Watson, S.P. & Machesky, L.M. (2013) Megakaryocytes assemble podosomes that degrade matrix and protrude through basement membrane. Blood, 121, 2542-2552.
88. Seligsohn, U. (2012) Treatment of inherited platelet disorders. Haemophilia, 18, 161-165.
89. Smith, H., Galmes, R., Gogolina, E., Straatman-Iwanowska, A., Reay, K., Banushi, B., Bruce, C.K., Cullinane, A.R., Romero, R., Chang, R., Akermann, O., Baumann, C., Cangul, H., Celik, F.C., Aygun, C., Coward, R., Dionisi-Vici, C., Sibbles, B., Inward, C., Kim, C., Klumperman, J., Knisely, A.S., Watson, S.P. & Gissen, P. (2012) Associations among genotype, clinical phenotype, and intracellular localization of trafficking proteins in ARC syndrome. Human Mutation, 33, 1656-1664.
90. Stevenson, W.S., Morel-Kopp, M.-C., Chen, Q., Liang, H.P., Bromhead, C.J., Wright, S., Turakulov, R., Ng, A.P., Roberts, A.W., Bahlo, M. & Ward, C.M. (2013) GFI1B mutation causes a bleeding disorder with abnormal platelet function. Journal of Thrombosis and Haemostasis, doi: 10.1111/jth.12368.
91. Suzuki, J., Umeda, M., Sims, P.J. & Nagata, S. (2010) Calcium-dependent phospholipid scrambling by TMEM16F. Nature, 468, 834-838.
92. Thrasher, A.J. & Burns, S.O. (2010) WASP: a key immunological multitasker. Nature Reviews Immunology, 10, 182-192.
93. Topalov, N.N., Yakimenko, A.O., Canault, M., Artemenko, E.O., Zakharova, N.V., Abaeva, A.A., Loosveld, M., Ataullakhanov, F.L., Nurden, A.T., Alessi, M.C. & Panteleev, M.A. (2012) Two types of procoagulant platelets are formed upon physiological activation and are controlled by integrin α(IIb)β(3). Arteriosclerosis, Thrombosis and Vascular Biology, 32, 2475-2483.
94. Urban, D., Li, L., Christensen, H., Pluthero, F.G., Chen, S.Z., Pulhacz, M., Garg, P.M., Lanka, K.K., Cummings, J.J., Kramer, H., Wasmuth, J.D., Parkinson, J. & Kahr, W.H.A. (2012) The VPS33B-binding protein, VPS16B is required in megakaryocyte and platelet α-granule biogenesis. Blood, 120, 5032-5040.
95. Van de Vijver, E., De Cuyper, I.M., Gerrits, A.J., Verhoeven, A.J., Seeger, K., Gutiérrez, L., van den Berg, T.K. & Kuijpers, T.W. (2012) Defects in Glanzmann thrombasthenia and LAD-III (LAD-1/v) syndrome: the role of integrin β1 and β3 in platelet adhesion to collagen. Blood, 119, 583-586.
96. Van Geet, C., Izzi, B., Labarque, V. & Freson, K. (2009) Human platelet pathology related to defects in the G-protein signaling cascade. Journal of Thrombosis and Haemostasis, 7, 282-286.
97. Van Kruchten, R., Mattheij, N.J.A., Daunders, C., Feijge, M.A.H., Swieringa, F., Wolfs, J.L.N., Collins, P.W., Heemskerk, J.W.M. & Bevers, E.M. (2013) Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation. Blood, 121, 1850-1857.
98. Varga-Szabo, D., Pleines, I. & Niesswandt, B. (2008) Cell adhesion mechanisms in platelets. Arteriosclerosis, Thrombosis and Vascular Biology, 28, 403-412.
99. Villeneuve, J., Block, A., Le Bousse-Kerdilés, M.C., Lepreux, S., Nurden, P., Ripoche, J. & Nurden, A.T. (2009) Tissue inhibitors of metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins. Experimental Hematology, 37, 849-856.
100. Watson, S., Daly, M., Dawood, B., Gissen, P., Makris, M., Mundell, S. & Wilde, J. (2010) Phenotypic approaches to gene mapping in platelet function disorders. Hämostaseologie, 30, 29-38.
101. 2+-activated cation channel required for lipid scrambling in platelets during blood coagulation. Cell, 151, 111-122.
102. Ye, S., Karim, Z.A., Al Hawas, R., Pessin, J.E., Filipovich, A.H. & Whiteheart, S.W. (2012) Syntaxin-11, but not syntaxin-2 or syntaxin-4, is required for platelet secretion. Blood, 120, 2484-2492.
103. Zhou, Z., Gushiken, F.C., Bolgiano, D., Salsbery, B.J., Aghakasiri, N., Jing, N., Wu, X., Vijayan, V., Rumbaut, R.E., Adachi, R., Lopez, J.A. & Dong, J.-F. (2013) Signal transducer and activator of transcription 3 (STAT3) regulates collagen-induced platelet aggregation independently of its transcription factor activity. Circulation, 127, 476-485.